SMS Lifesciences India Ltd - 540679 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Publication of Financial Results in Newspaper as per Reg. 47(1)(b) of SEBI Listing Regulations.22-08-2020
22-08-2020
SMS Lifesciences India Ltd - 540679 - Outcome of Board Meeting (AGM on Sept 30, 2020)
SMS Lifesciences India Ltd has informed BSE about Outcome of Board Meeting held on August 21, 2020.21-08-2020
SMS Lifesciences India Ltd - 540679 - Announcement under Regulation 30 (LODR)-Change in Directorate
Mr. Talluri Venkata Praveen is appointed as Additional Director (Whole-Time Director) on the Board of Directors of the Company and designated as "Executive Director" for a period of 5 years w.e.f. September 1, 2020, subject to approval of the Shareholders at the next Annual General Meeting of the Company21-08-2020
SMS Lifesciences India Ltd - 540679 - Unaudited Financial (Standalone And Consolidated) Results For Quarter Ended June 30, 2020
Disclosure under Regulation 33 read with sub-para 4 & 12 of Para "A" of Pari "A" of Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 201521-08-2020
SMS Lifesciences India Ltd - 540679 - Status Update On Ranitidine HCL.
This is in-furtherance to our earlier communication dated (i) 17.09.2019 (ii) 30.09.2019 (iii) 10.10.2019 (iv) 04.11.2019 and (v) 09.04.202019-08-2020
SMS Lifesciences India Ltd - 540679 - Board Meeting Intimation for Considering Financial Results Of Quarter Ended June 30, 2020.
SMS Lifesciences India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/08/2020 ,inter alia, to consider and approve Disclosure pursuant to Regulation 29 of the SEBI (LIsting Obligations & Disclosure Requirements) RegUlations, 2015 read aiong with SEBi Circular no. SEBI/HO/CFD/CMD1/CIR/P/2020/140 dated July 29,2020,14-08-2020
SMS Lifesciences India Ltd - 540679 - Clarification
With reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded, SMS Lifesciences India Ltd has submitted to BSE a copy of Clarification is enclosed.10-08-2020
SMS Lifesciences India Ltd - 540679 - Clarification sought from SMS Lifesciences India Ltd
The Exchange has sought clarification from SMS Lifesciences India Ltd on August 6, 2020 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited.06-08-2020
SMS Lifesciences India Ltd - 540679 - CONTACT DETAILS OF KEY MANAGERIAL PERSONNELS
Disclosure as per Regulation 30 (5) of SEBI (Listing Obligations & Disclosure Requirements) Regulation, 201530-07-2020